1. Home
  2. XCUR

XCUR

Exicure Inc.

Logo Exicure Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-24-2024 2:43pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.

Founded: 2011 Country:
N/A
Employees: N/A City: CHICAGO
Market Cap: 5.2M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 222.4K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 1.68 EPS Growth: N/A
52 Week Low/High: $0.36 - $1.50 Next Earning Date: 01-01-0001
Revenue: $23,790,000 Revenue Growth: 584.21%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: